Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species

This publication has 13 references indexed in Scilit:

• In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin
  Antimicrobial Agents and Chemotherapy, 1992
• Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP)
  Journal of Medicinal Chemistry, 1992
• Bacterial Etiologic Agents in the Pathogenesis of Urinary Tract Infection
  Medical Clinics of North America, 1991
• Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts
  Antimicrobial Agents and Chemotherapy, 1990
• pH and other effects on the antifungal activity of cilofungin (LY121019)
  Antimicrobial Agents and Chemotherapy, 1989
• Anti-Candida Activity and Toxicology of LY121019, a Novel Semisynthetic Polypeptide Antifungal Antibiotic
  Annals of the New York Academy of Sciences, 1988
• Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis
  Antimicrobial Agents and Chemotherapy, 1988
• In vitro and in vivo anti-Candida activity and toxicology of LY121019.
  The Journal of Antibiotics, 1984
• Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States
  Antimicrobial Agents and Chemotherapy, 1982
• Antimicrobial Susceptibility Testing of Yeasts: a Turbidimetric Technique Independent of Inoculum Size
  Antimicrobial Agents and Chemotherapy, 1976